Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Pharmaceuticals (Basel)

From Bioblast
Revision as of 20:08, 22 January 2021 by Plangger Mario (talk | contribs) (Created page with "{{Journal |Title=[https://www.mdpi.com/journal/pharmaceuticals Pharmaceuticals] }}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Journals in Bioblast
Journal title and website Pharmaceuticals

Publications

 ReferencePublishedView
Qvit 2022 Pharmaceuticals (Basel)Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Mochly-Rosen D (2022) A selective inhibitor of cardiac troponin I phosphorylation by delta protein kinase C (δPKC) as a treatment for ischemia-reperfusion injury. https://doi.org/10.3390/ph150302712022Pharmaceuticals (Basel) 15:271. PMID: 35337069 Open Access
Schiller 2022 Pharmaceuticals (Basel)Schiller J, Zickermann V (2022) Binding of natural inhibitors to respiratory complex I. https://doi.org/10.3390/ph150910882022Pharmaceuticals (Basel) 15:1088. PMID: 36145309 Open Access
Litwiniuk 2021 Pharmaceuticals (Basel)Litwiniuk A, Baranowska-Bik A, Domańska A, Kalisz M, Bik W (2021) Contribution of mitochondrial dysfunction combined with NLRP3 inflammasome activation in selected neurodegenerative diseases. Pharmaceuticals (Basel) 14:1221. https://doi.org/10.3390/ph141212212021PMID: 34959622 Open Access
Viel 2021 Pharmaceuticals (Basel)Viel C, Brandtner AT, Weißhaar A, Lehto A, Fuchs M, Klein J (2021) Effects of magnesium orotate, benfotiamine and a combination of vitamins on mitochondrial and cholinergic function in the TgF344-AD rat model of Alzheimer's disease. https://doi.org/10.3390/ph141212182021Pharmaceuticals (Basel) 14:1218. PMID: 34959619 Open Access
Robledo-Cadena 2020 Pharmaceuticals (Basel)Robledo-Cadena DX, Gallardo-Pérez JC, Dávila-Borja V, Pacheco-Velázquez SC, Belmont-Díaz JA, Ralph SJ, Blanco-Carpintero BA, Moreno-Sánchez R, Rodríguez-Enríquez S (2020) Non-steroidal anti-inflammatory drugs increase cisplatin, paclitaxel, and doxorubicin efficacy against human cervix cancer cells. Pharmaceuticals (Basel) 13:463.2020PMID: 33333716 Open Access